8-K//Current report
Aimmune Therapeutics, Inc. 8-K
Accession 0001193125-20-272122
CIK 0001631650operating
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 5:05 PM ET
Size
258.2 KB
Accession
0001193125-20-272122
Documents
- 8-Kd54871d8k.htmPrimary
8-K
- EX-3.1d54871dex31.htm
EX-3.1
- EX-3.2d54871dex32.htm
EX-3.2
- EX-101.SCHaimt-20201013.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABaimt-20201013_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREaimt-20201013_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLd54871d8k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-20-272122-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001631650
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 5:05 PM ET
- Size
- 258.2 KB